Windtree Therapeutics Inc (WINT)
0.4961
-0.01
(-2.59%)
USD |
NASDAQ |
Nov 22, 15:04
Windtree Therapeutics Total Assets (Quarterly): 28.71M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 28.71M |
March 31, 2024 | 30.10M |
December 31, 2023 | 32.41M |
September 30, 2023 | 36.06M |
June 30, 2023 | 40.58M |
March 31, 2023 | 35.18M |
December 31, 2022 | 37.95M |
September 30, 2022 | 48.10M |
June 30, 2022 | 51.81M |
March 31, 2022 | 67.11M |
December 31, 2021 | 74.79M |
September 30, 2021 | 84.82M |
June 30, 2021 | 90.86M |
March 31, 2021 | 135.89M |
December 31, 2020 | 112.88M |
September 30, 2020 | 118.53M |
June 30, 2020 | 128.32M |
March 31, 2020 | 112.99M |
December 31, 2019 | 118.98M |
September 30, 2019 | 100.63M |
June 30, 2019 | 105.24M |
March 31, 2019 | 111.63M |
December 31, 2018 | 119.40M |
September 30, 2018 | 1.943M |
June 30, 2018 | 1.979M |
Date | Value |
---|---|
March 31, 2018 | 2.967M |
December 31, 2017 | 3.347M |
September 30, 2017 | 4.657M |
June 30, 2017 | 5.825M |
March 31, 2017 | 11.71M |
December 31, 2016 | 9.699M |
September 30, 2016 | 16.43M |
June 30, 2016 | 25.00M |
March 31, 2016 | 34.71M |
December 31, 2015 | 44.38M |
September 30, 2015 | 52.73M |
June 30, 2015 | 28.20M |
March 31, 2015 | 38.12M |
December 31, 2014 | 47.50M |
September 30, 2014 | 58.31M |
June 30, 2014 | 69.47M |
March 31, 2014 | 79.50M |
December 31, 2013 | 89.32M |
September 30, 2013 | 23.63M |
June 30, 2013 | 33.91M |
March 31, 2013 | 29.16M |
December 31, 2012 | 29.94M |
September 30, 2012 | 39.75M |
June 30, 2012 | 49.18M |
March 31, 2012 | 57.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.71M
Minimum
Jun 2024
135.89M
Maximum
Mar 2021
72.95M
Average
67.11M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 1.287B |
AIM ImmunoTech Inc | 13.59M |
Perspective Therapeutics Inc | 391.15M |
Protalix BioTherapeutics Inc | 61.56M |
Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 25.21M |
Shareholders Equity (Quarterly) | 3.494M |